Bioprocess Capital Costs
by Mark Warner (Warner Advisors LLC/Biofuels Digest) Discussion of biotechnology capital costs is often a controversial topic, on par with discussing politics at the Thanksgiving dinner table; why the facilities are so expensive and a disbelief of the forecasted costs. As